• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:基于免疫疗法的联合方案在子宫原发性骨肉瘤中的临床应用

Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus.

作者信息

Yang Jing, Chen Xiaowen, Li Xiaofang, Liu Wenci, Liao Sihai, Wang Yuzhou, Zuo Yufang

机构信息

Department of Gynecological Oncology, Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Department of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

出版信息

Front Oncol. 2023 Jul 4;13:1198765. doi: 10.3389/fonc.2023.1198765. eCollection 2023.

DOI:10.3389/fonc.2023.1198765
PMID:37469418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10352772/
Abstract

Primary osteosarcoma of the uterus is an extremely rare pure heterologous sarcoma of the uterus. The relevant available information is limited to case reports. To date, only 31 cases of this type of cancer have been reported. Here, we report the first clinical experience with the administration of an immunotherapy-based combination regimen for multiple metastatic primary osteosarcomas of the uterus. The patient had undergone multiple treatments prior to this regimen, but her condition continued to progress. However, after 3 cycles of immunotherapy combined with targeted therapy and chemotherapy, a review showed that the disease was stable and even in partial remission. The patient has a good quality of life, and long-term survival is expected.

摘要

子宫原发性骨肉瘤是一种极其罕见的子宫纯异源性肉瘤。现有的相关信息仅限于病例报告。迄今为止,仅报道过31例此类癌症。在此,我们报告首例针对子宫多发性转移性原发性骨肉瘤采用基于免疫疗法的联合方案的临床经验。该患者在采用此方案之前已接受过多种治疗,但其病情仍持续进展。然而,在进行3个周期的免疫疗法联合靶向治疗和化疗后,复查显示病情稳定,甚至部分缓解。患者生活质量良好,有望长期生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/5d5e274658a4/fonc-13-1198765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/2e85f5cbb6e7/fonc-13-1198765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/7e3feda8f031/fonc-13-1198765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/5d5e274658a4/fonc-13-1198765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/2e85f5cbb6e7/fonc-13-1198765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/7e3feda8f031/fonc-13-1198765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1421/10352772/5d5e274658a4/fonc-13-1198765-g003.jpg

相似文献

1
Case Report: Clinical application of immunotherapy-based combination regimen in primary osteosarcoma of the uterus.病例报告:基于免疫疗法的联合方案在子宫原发性骨肉瘤中的临床应用
Front Oncol. 2023 Jul 4;13:1198765. doi: 10.3389/fonc.2023.1198765. eCollection 2023.
2
Primary osteosarcoma of the uterine corpus: A case report.子宫体原发性骨肉瘤:一例报告。
J Obstet Gynaecol Res. 2016 Nov;42(11):1604-1608. doi: 10.1111/jog.13079. Epub 2016 Jun 20.
3
Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report.吉西他滨联合多西他赛化疗方案治疗骨外骨肉瘤的长期疗效:病例报告
Oncol Lett. 2015 Jun;9(6):2567-2571. doi: 10.3892/ol.2015.3111. Epub 2015 Apr 14.
4
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].[含三氧化二砷的联合化疗用于Ⅲ期骨肉瘤和尤因肉瘤的初步报告]
Zhonghua Wai Ke Za Zhi. 2006 Jun 15;44(12):805-8.
5
Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?对于初诊时即发生转移的原发性骨恶性肿瘤患者,外科切除原发灶是否能提高总生存率?
Clin Orthop Relat Res. 2020 Oct;478(10):2284-2295. doi: 10.1097/CORR.0000000000001361.
6
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.西南肿瘤协作组与癌症和白血病B组针对晚期骨肉瘤、尤因肉瘤和横纹肌肉瘤成人患者开展的阿霉素、达卡巴嗪、异环磷酰胺及美司钠的II期研究。
Cancer. 1998 Apr 1;82(7):1288-95.
7
Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations-A Report of a Stunning Success in a 37-Year-Old Patient.病例报告:晚期转移性骨肉瘤的双重检查点抑制导致所有肿瘤表现缓解——一名37岁患者惊人成功的报告
Front Oncol. 2021 Aug 6;11:684733. doi: 10.3389/fonc.2021.684733. eCollection 2021.
8
Primary osteosarcoma of the heart with long-term survival: A case report of laparoscopic resection of a metastatic sarcoma in the intestine.心脏原发性骨肉瘤伴长期生存:腹腔镜切除肠道转移性肉瘤的病例报告
Oncol Lett. 2014 Oct;8(4):1599-1602. doi: 10.3892/ol.2014.2405. Epub 2014 Aug 1.
9
Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden.病例报告:高肿瘤突变负担的骨肉瘤序贯化疗和免疫治疗产生持续反应。
Front Endocrinol (Lausanne). 2021 Jun 18;12:625226. doi: 10.3389/fendo.2021.625226. eCollection 2021.
10
Recent progress in chemotherapy and immunotherapy of sarcomas of bony origin, both as primary and adjunctive therapy.骨源性肉瘤化疗和免疫治疗作为主要治疗及辅助治疗的近期进展。
J Surg Oncol. 1977;9(1):2-14. doi: 10.1002/jso.2930090103.

本文引用的文献

1
Clinicopathologic Features and Whole Genome Sequencing of a Primary Osteosarcoma of the Uterus.子宫原发性骨肉瘤的临床病理特征及全基因组测序
J Immunother Precis Oncol. 2020 Apr 28;3(2):90-95. doi: 10.36401/JIPO-19-34. eCollection 2020 May.
2
Primary uterine osteosarcoma arising in a leiomyoma with rapid local recurrence: A case report.源于平滑肌瘤并伴有快速局部复发的原发性子宫骨肉瘤:一例报告
Gynecol Oncol Rep. 2022 Nov 11;44:101102. doi: 10.1016/j.gore.2022.101102. eCollection 2022 Dec.
3
Primary osteosarcoma of the uterus: a report of two cases.
子宫原发性骨肉瘤:两例报告。
Ghana Med J. 2021 Sep;55(3):232-235. doi: 10.4314/gmj.v55i3.10.
4
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.软组织肉瘤,第 2.2022 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2022 Jul;20(7):815-833. doi: 10.6004/jnccn.2022.0035.
5
Turning cold tumors hot: from molecular mechanisms to clinical applications.使冷肿瘤变热:从分子机制到临床应用。
Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25.
6
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.仑伐替尼联合帕博利珠单抗治疗晚期子宫内膜癌患者:一项多中心、开放标签、单臂、2 期临床试验的中期分析。
Lancet Oncol. 2019 May;20(5):711-718. doi: 10.1016/S1470-2045(19)30020-8. Epub 2019 Mar 25.
7
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies.采用联合免疫疗法治疗免疫热、改变和冷肿瘤的方法。
Nat Rev Drug Discov. 2019 Mar;18(3):197-218. doi: 10.1038/s41573-018-0007-y.
8
Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma.安罗替尼,一种多激酶血管生成抑制剂,治疗耐药性转移性软组织肉瘤患者的安全性和疗效。
Clin Cancer Res. 2018 Nov 1;24(21):5233-5238. doi: 10.1158/1078-0432.CCR-17-3766. Epub 2018 Jun 12.
9
Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus.子宫体原发性骨肉瘤的临床病理特征及遗传学改变。
Int J Gynecol Pathol. 2019 Sep;38(5):414-419. doi: 10.1097/PGP.0000000000000511.
10
Primary osteosarcoma of the uterine corpus: A case report.子宫体原发性骨肉瘤:一例报告。
J Obstet Gynaecol Res. 2016 Nov;42(11):1604-1608. doi: 10.1111/jog.13079. Epub 2016 Jun 20.